Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
May River Capital is a Chicago-based private equity firm managing approximately $1 billion in assets. It focuses on lower middle-market industrial growth businesses across sectors like advanced manufacturing, engineered products, instrumentation, specialized industrial services, and value-added distribution. Since 2012, it has completed over 33 acquisitions across 15 platform companies, some of which indirectly serve pharmaceutical and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on May River Capital.